This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Metabasis Therapeutics, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oberlin, OH (US) (2013)
- Brooklyn, NY (US) (2013)
Company Filing History:
2 out of 2,405 
1 out of 64 Years Active: 2013
Title: The Innovative Contributions of David Wilson
Introduction
David Wilson is a notable inventor based in Oberlin, OH (US), recognized for his significant contributions to the field of medicinal chemistry. With a total of 2 patents to his name, Wilson has focused on developing novel compounds that address critical health issues.
Latest Patents
Wilson's latest patents include cyclic benzimidazole derivatives that are useful as anti-diabetic agents. These novel compounds are activators of AMP-protein kinase and are designed to treat, prevent, and suppress diseases mediated by the AMPK-activated protein kinase. Specifically, these compounds are beneficial in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.
Career Highlights
Throughout his career, Wilson has worked with prominent companies such as Merck Sharp & Dohme Corporation and Metabasis Therapeutics, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Wilson has collaborated with notable colleagues, including Brett C Bookser and Qun Dang, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
David Wilson's innovative work in developing anti-diabetic agents showcases his commitment to addressing significant health challenges. His contributions to medicinal chemistry continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile